.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
McKesson
Merck
Johnson and Johnson
Healthtrust
QuintilesIMS
Cipla
US Army
Medtronic
Teva

Generated: December 18, 2017

DrugPatentWatch Database Preview

Sun Pharma Global Company Profile

« Back to Dashboard

What is the competitive landscape for SUN PHARMA GLOBAL, and when can generic versions of SUN PHARMA GLOBAL drugs launch?

SUN PHARMA GLOBAL has seventy-two approved drugs.

There are three US patents protecting SUN PHARMA GLOBAL drugs. There are eight tentative approvals on SUN PHARMA GLOBAL drugs.

There are ninety-seven patent family members on SUN PHARMA GLOBAL drugs in forty-six countries and one hundred and forty-one supplementary protection certificates in thirteen countries.

Summary for Sun Pharma Global

International Patents:97
US Patents:3
Tradenames:62
Ingredients:61
NDAs:72
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharma GlobalKETOROLAC TROMETHAMINEketorolac tromethamineINJECTABLE;INJECTION078737-001Oct 6, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma GlobalESZOPICLONEeszopicloneTABLET;ORAL091103-001Apr 3, 2013ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma GlobalFOSPHENYTOIN SODIUMfosphenytoin sodiumINJECTABLE;INJECTION078417-001Mar 18, 2008APRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma GlobalIMATINIB MESYLATEimatinib mesylateTABLET;ORAL078340-002Dec 3, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma GlobalMEMANTINE HYDROCHLORIDEmemantine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL205905-002Sep 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma GlobalVENLAFAXINE HYDROCHLORIDEvenlafaxine hydrochlorideTABLET, EXTENDED RELEASE;ORAL091272-002Aug 18, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma GlobalTOPIRAMATEtopiramateTABLET;ORAL090278-003Mar 27, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma GlobalMEMANTINE HYDROCHLORIDEmemantine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL205905-004Sep 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma GlobalSUMATRIPTAN SUCCINATEsumatriptan succinateINJECTABLE;SUBCUTANEOUS090358-001Jun 21, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharma GlobalALPRAZOLAMalprazolamTABLET;ORAL090082-001Jun 17, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Sun Pharma Global Drugs

Country Document Number Estimated Expiration
San MarinoT201300072► Subscribe
Malaysia151100► Subscribe
European Patent Office2342198► Subscribe
Portugal2363393► Subscribe
Spain2418485► Subscribe
Cuba20080202► Subscribe
Ukraine93548► Subscribe
Spain2422557► Subscribe
Ukraine103049► Subscribe
Japan4897938► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Sun Pharma Global Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
00357Netherlands► SubscribePRODUCT NAME: SITAGLIPTINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVA ARDBAAR ZOUT, IN HET BIJZONDER HET MONOFOSFAAT, EN METFORMINE DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/08/455/001-014 20080716
923Luxembourg► SubscribePRODUCT NAME: UNE SOLUTION D'IRRIGATION OCULAIRE COMPRENANT DE LA PHENYLEPHRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI ET DU KETOROLAC OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; FIRST REGISTRATION: 20150730
2011 00026Denmark► SubscribePRODUCT NAME: A COMBINATION OF OLMESARTAN MEDOXOMIL, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, AND AMLODIPINE BESYLATE AND HYDROCHLOROTHIAZIDE; NAT. REG. NO/DATE: 46260-46269 (DK) 20110323; FIRST REG. NO/DATE: DE 79810.00.00 20101216
C0077France► SubscribePRODUCT NAME: SONIDEGIB OU SEL,HYDRATE,OU SOLVATE PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/15/1030 20150818
00C/015Belgium► SubscribePRODUCT NAME: QUETIAPINE FUMARAT (EQUIV. MET 25MG QUETIAPINE BASE); REGISTRATION NO/DATE: 624 S 309 F 3 20000207; FIRST REGISTRATION: GB PL 12619/0113 19970731
90023-0Sweden► SubscribePRODUCT NAME: ROSUVASTATIN
80022Netherlands► SubscribePRODUCT NAME: QUETIAPINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAAR DBAAR ZOUT, IN HET BIJZONDER QUETIAPINEFUMARAAT; NAT. REGISTRATION NO/DATE: RVG 20826 - RVG 20828 19980427; FIRST REGISTRATION: GB PL 12619/0112 - PL 12619/0114 19970731
C/GB97/010United Kingdom► SubscribePRODUCT NAME: GENERIC NAME: IRINOTECANCHEMICAL NAME: (+)-(4S)-4,11-DIETHYL-4-HYDROXY-9-((4-PIPERIDINOPIPERIDINO)CARBONYLOXY)-1H-PYRANO (3',4':6,7) INDOLIZINO(1,2-B) QUINOLINE-3,14-(4H,12H)-DIONE,OPTIONALLY THE HYDROCHLORIDE SALT THEREOF AND OPTIONALLY THE TRIHYDRATE T; REGISTERED: FR 558822.2 19950505; FR 558823.9 19950505; FR 558824.5 19950505; FR 558825.1 19950505; UK 00012/0302 19961017; UK 00012/0303 19961017
C0036Belgium► SubscribePRODUCT NAME: CLOPIDOGREL HYDROGENE SULFATE; REGISTRATION NO/DATE IN FRANCE: EU/1/98 /069/001 DU 19980715; REGISTRATION NO/DATE AT EEC: DU EU/1-/98/069/001
00688Netherlands► SubscribePRODUCT NAME: EZETIMIBE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, EN ROSUVASTATINE; NAT. REGISTRATION NO/DATE: RVG114002-004RVG 114008-010 2014110811; FIRST REGISTRATION: 13-9663 - 9665 20140724
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Chinese Patent Office
Citi
Accenture
Farmers Insurance
Johnson and Johnson
US Department of Justice
AstraZeneca
Moodys
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot